294 related articles for article (PubMed ID: 25760926)
21. Mechanisms for propofol in inhibiting the proliferation and invasion of glioma U87 cells and its effect on miR-134 expression.
Li F; Zhang H; Wang F; Zheng Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 46(1):18-24. PubMed ID: 33678632
[TBL] [Abstract][Full Text] [Related]
22. MiR-4524b-5p-targeting ALDH1A3 attenuates the proliferation and radioresistance of glioblastoma via PI3K/AKT/mTOR signaling.
Yu H; Li X; Li Y; Wang T; Wang M; Mao P
CNS Neurosci Ther; 2024 Feb; 30(2):e14396. PubMed ID: 37551838
[TBL] [Abstract][Full Text] [Related]
23. NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas.
Lim LM; Lee YC; Lin TW; Hong ZX; Hsu WC; Ke HL; Hwang DY; Chung WY; Li WM; Lin HH; Kuo HT; Huang AM
Kaohsiung J Med Sci; 2024 May; 40(5):445-455. PubMed ID: 38593276
[TBL] [Abstract][Full Text] [Related]
24. MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.
Wang YY; Zhou YQ; Xie JX; Zhang X; Wang SC; Li Q; Hu LP; Jiang SH; Yi SQ; Xu J; Cao H; Zhao EH; Li J
Cell Oncol (Dordr); 2023 Oct; 46(5):1429-1444. PubMed ID: 37249744
[TBL] [Abstract][Full Text] [Related]
25. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells.
Liu P; Wilson MJ
J Cell Physiol; 2012 Feb; 227(2):867-76. PubMed ID: 21898400
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials.
Davoodi-Moghaddam Z; Jafari-Raddani F; Delshad M; Pourbagheri-Sigaroodi A; Bashash D
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15293-15310. PubMed ID: 37594532
[TBL] [Abstract][Full Text] [Related]
27. RFC2 promotes aerobic glycolysis and progression of colorectal cancer.
Lou F; Zhang M
BMC Gastroenterol; 2023 Oct; 23(1):353. PubMed ID: 37821801
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with pancreatic ductal adenocarcinoma.
Xie P; Tan SY; Li HF; Tang HD; Zhou JH
J Gene Med; 2024 Jan; 26(1):e3570. PubMed ID: 37482968
[TBL] [Abstract][Full Text] [Related]
29. The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer.
Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
[TBL] [Abstract][Full Text] [Related]
30. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.
Zhang L; Wu J; Ling MT; Zhao L; Zhao KN
Mol Cancer; 2015 Apr; 14():87. PubMed ID: 26022660
[TBL] [Abstract][Full Text] [Related]
31. [Advanced research of mTOR and lung carcinoid tumors].
Zhang Z; Wang M
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):43-7. PubMed ID: 23327873
[TBL] [Abstract][Full Text] [Related]
32. Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo.
Kim H; Banerjee N; Barnes RC; Pfent CM; Talcott ST; Dashwood RH; Mertens-Talcott SU
Mol Carcinog; 2017 Jan; 56(1):197-207. PubMed ID: 27061150
[TBL] [Abstract][Full Text] [Related]
33. Curcumin affects autophagy of prolactinoma cells by upregulating miR-206 to exert antitumor effects.
Duan JF; Zhang QJ; Zhu J; Lu JH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23734. PubMed ID: 38764151
[TBL] [Abstract][Full Text] [Related]
34. Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mTOR pathway in gastric cancer.
Jin Y; Xia Y; Du H; Xiang T; Lan B; Wei S; Li H; Huang H
Biochem Biophys Res Commun; 2023 Dec; 689():149188. PubMed ID: 37976838
[TBL] [Abstract][Full Text] [Related]
35. Molecularly targeting the PI3K-Akt-mTOR pathway can sensitize cancer cells to radiotherapy and chemotherapy.
Wang Z; Huang Y; Zhang J
Cell Mol Biol Lett; 2014 Jun; 19(2):233-42. PubMed ID: 24728800
[TBL] [Abstract][Full Text] [Related]
36. Research of the unrecognised functions of miR-375 in prostate cancer cells.
Goztepe M; Eroglu O
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):212-218. PubMed ID: 38650131
[TBL] [Abstract][Full Text] [Related]
37. Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2.
Ezine E; Lebbe C; Dumaz N
Clin Transl Med; 2023 Oct; 13(10):e1464. PubMed ID: 37877351
[TBL] [Abstract][Full Text] [Related]
38. Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cells.
Chandrasekera P; Perfetto M; Lu C; Zhuo M; Bahudhanapati H; Li J; Chen WC; Kulkarni P; Christian L; Liu J; Yien YY; Yu C; Wei S
J Biol Chem; 2022 Aug; 298(8):102225. PubMed ID: 35780836
[TBL] [Abstract][Full Text] [Related]
39. Inulin alleviates perfluorooctanoic acid-induced intestinal injury in mice by modulating the PI3K/AKT/mTOR signaling pathway.
Zhang QY; Zhong MT; Gi M; Chen YK; Lai MQ; Liu JY; Liu YM; Wang Q; Xie XL
Environ Pollut; 2024 Feb; 342():123090. PubMed ID: 38072026
[TBL] [Abstract][Full Text] [Related]
40. FATP2 activates PI3K/Akt/mTOR pathway by inhibiting ATF3 and promotes the occurrence and development of bladder cancer.
Jiang M; Chen R; Hu B; Xiong S; Li S; Fu B; Liu X
Cell Signal; 2024 May; 117():111087. PubMed ID: 38316266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
